Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
<h4>Background</h4>Nicorandil, as an adjunctive therapy with primary percutaneous coronary intervention (PCI), had controversial benefits in cardioprotection in patients with acute myocardial infarction (AMI).<h4>Methods and results</h4>We performed a systematic review of ran...
Saved in:
Main Authors: | Muli Wu, Zheng Huang, Haojun Xie, Zhongjiang Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0078231 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
by: G. N. Soboleva, et al.
Published: (2019-06-01) -
CARDIOPROTECTION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: IVAN E. Vereschagin, et al.
Published: (2017-12-01) -
THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01) -
Postmyocardial syndrome after myocardial infarction and percutaneous coronary intervention
by: A. A. Klimenko, et al.
Published: (2024-12-01) -
LIMITATIONS ON PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION IN THE CLINICAL PRACTICE
by: V. V. Kashtalap, et al.
Published: (2016-03-01)